Skip to main content
Clinical Trials/NCT06197737
NCT06197737
Completed
Not Applicable

Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.

Riphah International University1 site in 1 country78 target enrollmentMarch 1, 2023
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Riphah International University
Enrollment
78
Locations
1
Primary Endpoint
Assessment of change in the Inspiratory Capacity
Status
Completed
Last Updated
last year

Overview

Brief Summary

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Detailed Description

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
January 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients having chronic asthma
  • Age between 15-25 years.
  • Participants having no dyspnea at rest .
  • Participants scoring 13 or less on borg scale
  • Exclusion Criteria
  • History of co-morbidities.
  • History of recent fractures.
  • Participants scoring greater than 13 on BORG scale

Exclusion Criteria

  • Exercise induced asthma (evaluated through BRUCE protocol).
  • Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
  • Patients score falling 15 or more on Borg scale.

Outcomes

Primary Outcomes

Assessment of change in the Inspiratory Capacity

Time Frame: Baseline, 8th week and then 16th week

It will measured using an incentive spirometer

Assessment of change in the Oxygen saturation

Time Frame: Baseline, 8th week and then 16th week

Measured using pulse oximeter before, during and after the intervention.

Assessment of change in the Pulmonary Function

Time Frame: Baseline, 8th week and then 16th week

Electronic spirometer will be used to measure all the parameters of pulmonary function.

Assessment of change in the Rate of perceived exertion / dyspnea

Time Frame: Baseline, 8th week and then 16th week

measured through borg scale during the assigned intervention

Assessment of change in the cardiovascular endurance

Time Frame: Baseline, 8th week and then 16th week

PACER test for cardiovascular endurance test

Study Sites (1)

Loading locations...

Similar Trials